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background: Decreasing the mobilization of Ly6Chigh monocytes after acute myocardial infarction (AMI) could be favorable to patients. 
We aimed to test whether therapeutic siCCR2-loaded photoluminescent mesoporous silicon nanoparticles (PMSNs) targeting CCR2 in 
Ly6Chigh monocytes could decrease the accumulation of the cells in infarcts, and improve the efficacy of mesenchymal stromal cells (MSCs) 
transplantation. 
methods: After AMI mice were prepared, 105 EdU-labeled MSCs were infused through intramyocardial injection. PMSNs-siCCR2 (25ug/g) 
was also injected via tail vein in the meanwhile. In vivo PMSNs-siCCR2 was examined using near-infrared imaging. Therapeutic effects of 
PMSNs-siCCR2 for MSCs transplantation were determined at mRNA, protein and functional levels. 
Results:  PMSNs-siCCR2 showed higher cellular localization of Ly6Chigh monocytes in the spleen and more efficient degradation of CCR2 
(%) compared with control (8.04±2.17 vs. 20.02±4.55, p<0.001). Reduced accumulation of CD11b (%) positive monocytes to the infarct 
(49.3±17.34 vs. 61.32±22.43, p<0.001) was first observed on day 1. Increased survival of transplanted MSCs (13±3/mm2 vs. 4±1/mm2, 
p<0.001) was identified in the infarct on day 3. 21 days after MSCs infusion, significantly ameliorated left ventricular (LV) remodeling (Fig.1, 
p<0.001) was shown. 
conclusion: PMSN-siCCR2 facilitated silencing of CCR2 gene in Ly6Chigh monocytes, benefited MSCs transplantation and selectively 
curbed myocardial remodeling.
 
